Written Question·Department of Health and Social Care·UIN 119738
Donanemab and Lecanemab
Tabled: 10 March 2026
Answered: 19 March 2026
Named DayQuestion
Freddie van Mierlo
Liberal Democrat — Henley and Thame
To ask the Secretary of State for Health and Social Care, when he expects NICE to publish the outcomes of the appeals on its final draft guidance on donanemab and lecanemab.
Answer
Dr Zubir AhmedThe appeals against the National Institute for Health and Care Excellence (NICE) recommendations on donanemab and lecanemab for the treatment of Alzheimer’s disease were heard by NICE’s independent appeal panel in January. The next steps of the appraisal ...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 119738) →